Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Awarded on September 30, 2025. Full description on SAM.gov.
Overview
- Posted
- December 21, 2025
- Notice type
- Award Notice
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIAID
- Place of performance
- Boston, Massachusetts, 02215
- Last updated
- Nov 4, 2026
- First published
- Last updated on SAM.gov
- Award date
- Sep 30, 2025
- Award amount (SAM.gov award notice)
- $10.0K
Identifiers
- Solicitation number
- 7529
- Notice ID
- 1091b1577ea146b886ae4a81a852fb45
- Award number (PIID)
- 75N93025D00019
Description
- IDIQ Guaranteed Minimum: $10,000 - Amount Obligated on Base IDIQ Contract Award
- Maximum Ordering Limit: $136,578,701
Award Overview
Award Number
75N93025D00019
Award Amount (SAM.gov award notice)
$10.0K
Award Date
Sep 30, 2025
Awardee
Awardee UEI
LMCPJJHMMFH3
Awardee CAGE Code
1LVP2
Awardee Address
Boston, MA 02215, UNITED STATES
Line Item Number
75N93025D00019
Original Solicitation
Notice ID: 1091b1577ea146b886ae4a81a852fb45
Posted Date: Dec 21, 2025
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 10, 2026
- $2.3MSigned Nov 3, 2026
- —Signed Aug 7, 2026
- $2.4MSigned Apr 3, 2026
- $13.7MSigned Jan 29, 2026
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
- 2Version 2SolicitationArchived
A--EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES
- 5Version 5Award NoticeArchivedCurrent
Type changed from Solicitation to Award Notice
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Other notices for this solicitation
- 3×Market ResearchJun 16, 2020
�In Vitro Assessment for Antimicrobial Activity Against SARS-CoV-2�
- AwardedRelated noticeDec 21, 2025
Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
A--EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
- AwardedRelated noticeDec 21, 2025
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Similar Opportunities
No similar opportunities found
No similar opportunities match this opportunity's profile.
Additional Details
Solicitation Number
7529
Archive Date
Jan 4, 2026
Office Address
BETHESDA, MD, 20892